FDA Approves Lurbinectedin Plus Atezolizumab for Maintenance in Extensive-Stage Small Cell Lung Cancer

FDA Approves Lurbinectedin Plus Atezolizumab for Maintenance in Extensive-Stage Small Cell Lung Cancer

60 questions about SCLC with Dr. Gregory Kalemkerian Part 1

Gregory Kalemkerian

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Paving the Way for a Smoke-Free Generation by 2040 - European Cancer Organisation

European Cancer Organisation

Fumiko Ladd Chino: Medical Debt in Patients Receiving Radiation

Fumiko Ladd Chino

iEXPLORE Phase I Trial: Engineered Exosomes with KRASG12D siRNA in Pancreatic Cancer

iEXPLORE

Senator Elissa Slotkin in Response to OncoDaily About Pediatric Cancer Funding

senator elissa slotkin

Patrick Soon-Shiong: New Data with Bioshield Worth Pushing for an RCT in HPV+ HNCC

Patrick Soon-Shiong

K.A. Gelmon